Igc pharma named top 15 finalist in nia prepare challenge for ai-driven early detection of alzheimer's disease

Potomac, md / access newswire / january 28, 2025 / igc pharma, inc. (nyse american:igc) ("igc pharma" or the "company") is proud to announce its selection as one of the top 15 finalists in the prepare challenge - phase 2: model arena (acoustic track), organized by the national institute on aging (nia). this recognition highlights igc's innovative application of artificial intelligence (ai) and machine learning to advance early detection of alzheimer's disease (ad) and improve patient outcomes.
IGC Ratings Summary
IGC Quant Ranking